The anticipated roll-out in Africa of an affordable birth dose vaccine to fight hepatitis B, a viral infection that attacks the liver, is expected to bolster the fight against the virus in the region that bears the brunt of the disease.

Africa accounts for 63% of all new hepatitis B…